Analysis of RNA-seq data from the CCLE database revealed that FOXP1 expression levels (log2 TPM + 1) were relatively elevated in hematologic malignancy-derived cell lines, particularly those corresponding to DLBCL, AML, and acute lymphoblastic leukemia (ALL), compared to cell lines from other tumor types (Figure 1A). Here, FOXP1 is linked to diffuse large B-cell lymphoma.